Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data
- PMID: 29124088
- PMCID: PMC5671473
- DOI: 10.1016/j.dib.2017.10.024
Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data
Abstract
[18F]-AV-1451 is a leading tracer used with positron emission tomography (PET) to quantify tau pathology. However, [18F]-AV-1451 shows "off target" or non-specific binding, which we define as binding of the tracer in unexpected areas unlikely to harbor aggregated tau based on autopsy literature [1]. Along with caudate, putamen, pallidum and thalamus non-specific binding [2], [3], we have found binding in the superior portion of the cerebellar gray matter, leading us to use inferior cerebellar gray as the reference region. We also addressed binding in the posterior portion of the choroid plexus. PET signal unlikely to be associated with tau also occurs in skull, meninges and soft tissue (see e.g. [4]). We refer to [18F]-AV-1451 binding in the skull and meninges as extra-cortical hotspots (ECH) and find them near lateral and medial orbitofrontal, lateral occipital, inferior and middle temporal, superior and inferior parietal, and inferior cerebellar gray matter. Lastly, the choroid plexus also shows non-specific binding that bleeds into hippocampus. We are providing the code (http://www.runmycode.org/companion/view/2798) used to create different regions of interest (ROIs) that we then used to perform Partial Volume Correction (PVC) using the Rousset geometric transfer matrix method (GTM, [5]). This method was used in the companion article, "Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease" ([6], DOI 10.1016/j.neuroimage.2017.05.058).
Figures







Similar articles
-
Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span.J Nucl Med. 2019 Oct;60(10):1444-1451. doi: 10.2967/jnumed.118.224113. Epub 2019 Mar 15. J Nucl Med. 2019. PMID: 30877180 Free PMC article.
-
Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019. Front Neurol. 2019. PMID: 31156534 Free PMC article.
-
[18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series.Acta Neuropathol Commun. 2019 Oct 28;7(1):164. doi: 10.1186/s40478-019-0808-1. Acta Neuropathol Commun. 2019. PMID: 31661038 Free PMC article.
-
Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer's Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study.Front Aging Neurosci. 2018 Jul 18;10:223. doi: 10.3389/fnagi.2018.00223. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30072890 Free PMC article.
-
Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23. J Mov Disord. 2018. PMID: 29381890 Free PMC article. Review.
Cited by
-
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding.J Alzheimers Dis. 2023;91(2):637-651. doi: 10.3233/JAD-220812. J Alzheimers Dis. 2023. PMID: 36463452 Free PMC article.
-
Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.Ann Neurol. 2020 Nov;88(5):921-932. doi: 10.1002/ana.25878. Epub 2020 Aug 31. Ann Neurol. 2020. PMID: 32799367 Free PMC article.
-
Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer's Disease.J Alzheimers Dis Rep. 2021 Jan 20;5(1):41-48. doi: 10.3233/ADR-200245. J Alzheimers Dis Rep. 2021. PMID: 33681715 Free PMC article.
-
Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain.Neurobiol Aging. 2022 Jul;115:1-11. doi: 10.1016/j.neurobiolaging.2022.03.005. Epub 2022 Mar 14. Neurobiol Aging. 2022. PMID: 35447369 Free PMC article.
-
18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.Alzheimers Res Ther. 2019 Jan 31;11(1):13. doi: 10.1186/s13195-019-0470-7. Alzheimers Res Ther. 2019. PMID: 30704514 Free PMC article.
References
-
- Braak H., Braak E. Neuropathological stageing in Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259. - PubMed
-
- Marquié M., Normandin M.D., Vanderburg C.R., Costantino I.M., Bien E.A., Rycyna L.G., Klunk W.E., Mathis C.A., Ikonomovic M.D., Debnath M.L., Vasdev N., Dickerson B.C., Gomperts S.N., Growdon J.H., Johnson K.A., Frosch M.P., Hyman B.T., Gómez-Isla T. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann. Neurol. 2015;78:787–800. - PMC - PubMed
-
- Marquié M., Normandin M.D., Meltzer A.C., Siao Tick Chong M., Andrea N.V., Antón-Fernández A., Klunk W.E., Mathis C.A., Ikonomovic M.D., Debnath M., Bien E.A., Vanderburg C.R., Costantino I., Makaretz S., DeVos S.L., Oakley D.H., Gomperts S.N., Growdon J.H., Domoto-Reilly K., Lucente D., Dickerson B.C., Frosch M.P., Human B.T., Johnson K.A., Gómez-Isla T. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann. Neurol. 2017;81:117–128. - PMC - PubMed
-
- Lowe V.J., Curran G., Fang P., Liesinger A.M., Josephs K.A., Parisi J.E., Kantarci K., Boeve B.F., Pandey M.K., Bruinsma T., Knopman D.S., Jones D.T., Petrucelli L., Cook C.N., Graff-Radford N.R., Dickson D.W., Petersen R.C., Jack C.R., Jr, Murray M.E. An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol. Commun. 2016;4:58. - PMC - PubMed
-
- Rousset O.G., Ma Y., Evans A.C. Correction for partial volume effects in PET: principle and validation. J. Nucl. Med. 1998;39:904–911. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources